当前位置: 首页 > 详情页

Up-regulated lipocalin-2 in pediatric thyroid cancer correlated with poor clinical characteristics

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Beijing Children’s Hospital, National Center for Children’s Health, Capital Medical University, No. 56 Nanlishi Road, Beijing 100045, China [2]Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Children’s Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing 100045, China [3]Department of Pathology, Beijing Children’s Hospital, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: Pediatric thyroid cancer Lipocalin-2 (Lcn2) NFB Ki-67

摘要:
BackgroundThe incidence of thyroid cancer is fast increasing in both adults and children. The pediatric thyroid cancer had often already progressed to a more advanced stage of the disease at diagnosis. Early detection of pediatric thyroid cancer has been a problem for many years. Lipocalin-2 (Lcn2) has been reported to be over-expressed in cancers of diverse histological origin and it facilitates tumorigenesis by promoting survival, growth, and metastasis.MethodsThe plasma Lcn2 concentration of 28 Chinese papillary thyroid cancer (PTC) children and 24 healthy controls was measured. Immunostaining for Ki-67 of tumor tissue from PTC children was performed. The expression levels of Lcn2 and NFB in PTC tissue and peri-carcinoma tissue of PTC children were measured through Western blot.ResultsThe plasma concentration of Lcn2 was significantly elevated in pediatric PTC patients compared with healthy controls. Besides, the plasma Lcn2 concentration significantly correlated with clinical characteristics, NFB level, and Ki-67 positive rate of nucleus in tissue of PTC.ConclusionThis is the first study to evaluate the plasma Lcn2 in pediatric PTC patients. It is possible that the plasma Lcn2 may be a new biomarker of pediatric thyroid cancer. Further studies are needed to explore the definite role and mechanism of Lcn2 in thyroid cancer, which will help to explore novel diagnostic or therapeutic strategies.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 3 区 耳鼻喉科学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 耳鼻喉科学
JCR分区:
出版当年[2016]版:
Q2 OTORHINOLARYNGOLOGY
最新[2023]版:
Q2 OTORHINOLARYNGOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Beijing Children’s Hospital, National Center for Children’s Health, Capital Medical University, No. 56 Nanlishi Road, Beijing 100045, China [2]Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Children’s Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing 100045, China
共同第一作者:
通讯作者:
通讯机构: [1]Beijing Children’s Hospital, National Center for Children’s Health, Capital Medical University, No. 56 Nanlishi Road, Beijing 100045, China [2]Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Children’s Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing 100045, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院